US Stock MarketDetailed Quotes

Reviva Pharmaceuticals (RVPH)

Watchlist
  • 0.3598
  • +0.0094+2.68%
Close Jan 16 16:00 ET
  • 0.3500
  • -0.0098-2.72%
Post 16:17 ET
42.04MMarket Cap-0.82P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Reviva Pharmaceuticals (RVPH) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-52.38%4.03M
-25.30%6.07M
-17.47%6.54M
-22.04%30.8M
-34.67%6.28M
-26.82%8.46M
-28.28%8.13M
13.42%7.92M
39.94%39.5M
-17.76%9.62M
Selling and administrative expenses
18.34%1.9M
-7.74%2.35M
13.39%2.42M
-2.38%7.89M
6.05%1.6M
-19.46%1.6M
-17.34%2.55M
42.50%2.14M
50.85%8.08M
2.42%1.51M
-General and administrative expense
18.34%1.9M
-7.74%2.35M
13.39%2.42M
-2.38%7.89M
6.05%1.6M
-19.46%1.6M
-17.34%2.55M
42.50%2.14M
50.85%8.08M
2.42%1.51M
Research and development costs
-68.92%2.13M
-33.30%3.72M
-28.88%4.11M
-27.09%22.91M
-42.26%4.68M
-28.35%6.86M
-32.36%5.58M
5.47%5.78M
37.38%31.42M
-20.67%8.11M
Operating profit
52.38%-4.03M
25.30%-6.07M
17.47%-6.54M
22.04%-30.8M
34.67%-6.28M
26.82%-8.46M
28.28%-8.13M
-13.42%-7.92M
-39.94%-39.5M
17.76%-9.62M
Net non-operating interest income expense
17.45%56.5K
-78.11%18.05K
-56.08%74.49K
-5.98%342.87K
-1.26%42.7K
-43.98%48.1K
-8.71%82.46K
21.71%169.61K
99.50%364.69K
-62.09%43.25K
Non-operating interest income
11.00%59.1K
-73.92%22.85K
-50.25%86.11K
-9.30%361.37K
-16.17%47.41K
-41.97%53.25K
-15.01%87.61K
17.74%173.1K
117.95%398.41K
-50.43%56.56K
Non-operating interest expense
-49.38%2.61K
-6.91%4.8K
233.24%11.62K
-45.15%18.5K
-64.61%4.71K
-12.79%5.15K
-59.61%5.15K
-54.45%3.49K
--33.73K
--13.31K
Other net income (expense)
-171.12%-34.59K
-95.23%9.28K
-88.95%36.05K
630.52%556.73K
-105.94%-12.84K
-66.29%48.63K
142.67%194.65K
9,787.74%326.28K
46.10%-104.94K
148.06%216.25K
Gain on sale of security
-138.46%-27.82K
-94.44%11.13K
-86.59%61.19K
400.00%717.65K
-116.67%-11.13K
-48.00%72.32K
143.90%200.27K
4,000.10%456.18K
-22.86%-239.22K
114.46%66.76K
Other non- operating income (expenses)
71.40%-6.77K
67.09%-1.85K
80.64%-25.15K
-219.84%-160.92K
-101.15%-1.71K
-556.05%-23.69K
-29,484.21%-5.62K
-796.19%-129.89K
--134.28K
--149.5K
Income before tax
52.09%-4.01M
23.01%-6.05M
13.45%-6.43M
23.81%-29.9M
33.17%-6.25M
26.19%-8.37M
32.89%-7.85M
-8.43%-7.43M
-38.96%-39.24M
22.21%-9.36M
Income tax
2.84K
7.70%7.95K
-29.52%5.21K
15.13%19.51K
203.30%4.73K
0
14.75%7.39K
148.35%7.4K
-18.42%16.95K
-154.79%-4.58K
Net income
52.06%-4.01M
22.98%-6.05M
13.46%-6.43M
23.79%-29.92M
33.09%-6.26M
26.27%-8.37M
32.87%-7.86M
-8.49%-7.43M
-38.92%-39.26M
22.30%-9.36M
Net income continuous Operations
52.06%-4.01M
22.98%-6.05M
13.46%-6.43M
23.79%-29.92M
33.09%-6.26M
26.27%-8.37M
32.87%-7.86M
-8.49%-7.43M
-38.92%-39.26M
22.30%-9.36M
Minority interest income
Net income attributable to the parent company
52.06%-4.01M
22.98%-6.05M
13.46%-6.43M
23.79%-29.92M
33.09%-6.26M
26.27%-8.37M
32.87%-7.86M
-8.49%-7.43M
-38.92%-39.26M
22.30%-9.36M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
52.06%-4.01M
22.98%-6.05M
13.46%-6.43M
23.79%-29.92M
33.09%-6.26M
26.27%-8.37M
32.87%-7.86M
-8.49%-7.43M
-38.92%-39.26M
22.30%-9.36M
Basic earnings per share
76.00%-0.06
53.85%-0.12
48.00%-0.13
45.45%-0.9
54.55%-0.15
47.92%-0.25
50.00%-0.26
19.35%-0.25
-13.79%-1.65
43.10%-0.33
Diluted earnings per share
76.00%-0.06
53.85%-0.12
48.00%-0.13
45.45%-0.9
54.55%-0.15
47.92%-0.25
50.00%-0.26
19.35%-0.25
-13.79%-1.65
43.10%-0.33
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -52.38%4.03M-25.30%6.07M-17.47%6.54M-22.04%30.8M-34.67%6.28M-26.82%8.46M-28.28%8.13M13.42%7.92M39.94%39.5M-17.76%9.62M
Selling and administrative expenses 18.34%1.9M-7.74%2.35M13.39%2.42M-2.38%7.89M6.05%1.6M-19.46%1.6M-17.34%2.55M42.50%2.14M50.85%8.08M2.42%1.51M
-General and administrative expense 18.34%1.9M-7.74%2.35M13.39%2.42M-2.38%7.89M6.05%1.6M-19.46%1.6M-17.34%2.55M42.50%2.14M50.85%8.08M2.42%1.51M
Research and development costs -68.92%2.13M-33.30%3.72M-28.88%4.11M-27.09%22.91M-42.26%4.68M-28.35%6.86M-32.36%5.58M5.47%5.78M37.38%31.42M-20.67%8.11M
Operating profit 52.38%-4.03M25.30%-6.07M17.47%-6.54M22.04%-30.8M34.67%-6.28M26.82%-8.46M28.28%-8.13M-13.42%-7.92M-39.94%-39.5M17.76%-9.62M
Net non-operating interest income expense 17.45%56.5K-78.11%18.05K-56.08%74.49K-5.98%342.87K-1.26%42.7K-43.98%48.1K-8.71%82.46K21.71%169.61K99.50%364.69K-62.09%43.25K
Non-operating interest income 11.00%59.1K-73.92%22.85K-50.25%86.11K-9.30%361.37K-16.17%47.41K-41.97%53.25K-15.01%87.61K17.74%173.1K117.95%398.41K-50.43%56.56K
Non-operating interest expense -49.38%2.61K-6.91%4.8K233.24%11.62K-45.15%18.5K-64.61%4.71K-12.79%5.15K-59.61%5.15K-54.45%3.49K--33.73K--13.31K
Other net income (expense) -171.12%-34.59K-95.23%9.28K-88.95%36.05K630.52%556.73K-105.94%-12.84K-66.29%48.63K142.67%194.65K9,787.74%326.28K46.10%-104.94K148.06%216.25K
Gain on sale of security -138.46%-27.82K-94.44%11.13K-86.59%61.19K400.00%717.65K-116.67%-11.13K-48.00%72.32K143.90%200.27K4,000.10%456.18K-22.86%-239.22K114.46%66.76K
Other non- operating income (expenses) 71.40%-6.77K67.09%-1.85K80.64%-25.15K-219.84%-160.92K-101.15%-1.71K-556.05%-23.69K-29,484.21%-5.62K-796.19%-129.89K--134.28K--149.5K
Income before tax 52.09%-4.01M23.01%-6.05M13.45%-6.43M23.81%-29.9M33.17%-6.25M26.19%-8.37M32.89%-7.85M-8.43%-7.43M-38.96%-39.24M22.21%-9.36M
Income tax 2.84K7.70%7.95K-29.52%5.21K15.13%19.51K203.30%4.73K014.75%7.39K148.35%7.4K-18.42%16.95K-154.79%-4.58K
Net income 52.06%-4.01M22.98%-6.05M13.46%-6.43M23.79%-29.92M33.09%-6.26M26.27%-8.37M32.87%-7.86M-8.49%-7.43M-38.92%-39.26M22.30%-9.36M
Net income continuous Operations 52.06%-4.01M22.98%-6.05M13.46%-6.43M23.79%-29.92M33.09%-6.26M26.27%-8.37M32.87%-7.86M-8.49%-7.43M-38.92%-39.26M22.30%-9.36M
Minority interest income
Net income attributable to the parent company 52.06%-4.01M22.98%-6.05M13.46%-6.43M23.79%-29.92M33.09%-6.26M26.27%-8.37M32.87%-7.86M-8.49%-7.43M-38.92%-39.26M22.30%-9.36M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 52.06%-4.01M22.98%-6.05M13.46%-6.43M23.79%-29.92M33.09%-6.26M26.27%-8.37M32.87%-7.86M-8.49%-7.43M-38.92%-39.26M22.30%-9.36M
Basic earnings per share 76.00%-0.0653.85%-0.1248.00%-0.1345.45%-0.954.55%-0.1547.92%-0.2550.00%-0.2619.35%-0.25-13.79%-1.6543.10%-0.33
Diluted earnings per share 76.00%-0.0653.85%-0.1248.00%-0.1345.45%-0.954.55%-0.1547.92%-0.2550.00%-0.2619.35%-0.25-13.79%-1.6543.10%-0.33
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +3.11%
Sample Name
Sample Code
 +2.53%
Sample Name
Sample Code
 +2.08%
4
Tempus AI
TEM
+2.05%
5
Block
XYZ
+1.59%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +11.41%
Sample Name
Sample Code
 +10.03%
Sample Name
Sample Code
 +9.57%
4
Kingsoft Cloud
KC
+7.99%
5
United Microelectronics
UMC
+5.80%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -